Viridian Therapeutics, Inc. (VRDN)
27.44
-0.66
(-2.35%)
USD |
NASDAQ |
Feb 20, 16:00
26.60
-0.84
(-3.06%)
After-Hours: 20:00
Viridian Therapeutics SG&A Expense (Quarterly) : 24.32M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 1.024M |
| ADMA Biologics, Inc. | 23.05M |
| Avantor, Inc. | 392.40M |
| Immunovant, Inc. | 15.44M |
| Plus Therapeutics, Inc. | 3.443M |